The global acute lymphoblastic leukemia (ALL) market is witnessing steady expansion, driven by increasing disease awareness, advancements in cancer diagnostics, and the development of innovative treatment options. Acute lymphoblastic leukemia is an aggressive form of blood cancer that affects immature white blood cells, particularly lymphocytes, and primarily originates in the bone marrow. The...